ezogabine

chemical compound
rdfs:label
"ezogabine"@en
skos:altLabel
"AWD-21360"@en
"D-23129"@en
"EZG"@en
"Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate"@en
"Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate"@en
"Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate"@en
"Ezogabine"@en
"N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester"@en
"N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester"@en
"Potiga®"@en
"RTG"@en
"Retigabine"@en
"Trobalt®"@en
"WAY-143841"@en
"ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate"@en
"retigabine"@en
schema:description
"chemical compound"@en
schema:dateModified "2026-11-04T09:40:30+00:00"^^xsd:dateTime
schema:version 2564638548
wikibase:identifiers 35
wikibase:sitelinks 13
wikibase:statements 60
p:P10245 wd:statement/Q2146170-6c224bd1-49fd-3f00-2d13-bad6db7caf29
p:P11089 wd:statement/Q2146170-ED2A092F-7479-4DE0-AEFC-A029C4D7B24D
p:P11198 wd:statement/Q2146170-39FDF75F-07F9-4345-836C-744326E0114B
p:P11199 wd:statement/Q2146170-0D7DAAE1-5734-4978-8273-6CAF046BB612
p:P117 wd:statement/Q2146170-F760ADCB-67C1-4B9B-9AAD-0931D67F0349
p:P129 wd:statement/Q2146170-24057D37-8FF2-494A-846C-FAC9F89A783E
wd:statement/Q2146170-53AA30E3-7F9B-422A-8F42-828E75000098
wd:statement/Q2146170-657D98F2-9A49-46E8-9164-A20CA4987CC6
wd:statement/Q2146170-7E2BA4EA-DC1F-4947-A36E-A3ADFCF0E478
wd:statement/Q2146170-8E388D71-600F-4322-8FF5-FF61719EC4BE
wd:statement/Q2146170-D9FEDAC5-64F6-402D-8AD5-AFFAF574406B
wd:statement/Q2146170-F98784DF-F094-405A-9D98-163FF8C060D9
p:P14834 wd:statement/Q2146170-8F7CC263-439D-4E94-A0EB-FA6580B1C10C
p:P1579 wd:statement/Q2146170-66D02B2B-1381-4158-BA66-E778DDA73452
p:P2057 wd:statement/Q2146170-8E008E24-4EE1-4F01-9BA7-16F875DEF5DC
p:P2062 wd:statement/Q2146170-8BD6175A-579F-488D-A137-12F42C747FCB
p:P2067 wd:statement/Q2146170-6347652D-C976-4392-BBFF-EB44700893EB
p:P2115 wd:statement/Q2146170-D76DB819-9C88-425D-AA0A-B24572DE0EA1
p:P2175 wd:statement/Q2146170-B9A54F69-AA97-4B31-9956-2C2513B2BC19
p:P2275 wd:statement/Q2146170-AA51E4F3-7E9E-4645-9911-5257DFA3760A
p:P231 wd:statement/Q2146170-2A23DC45-C5BF-4865-B5BE-4A1D8F5D305C
p:P232 wd:statement/Q2146170-4E4EEC37-37BE-4BC8-99C7-F91971186D92
p:P233 wd:statement/Q2146170-61C4813A-8E4F-4F80-B960-58AEE2444865
p:P234 wd:statement/Q2146170-68E68CB1-16DB-472C-8EF4-F96A5B225971
p:P235 wd:statement/Q2146170-117CE001-E27A-4102-AAB1-72973EA7CDF7
p:P244 wd:statement/Q2146170-F8561017-C7ED-480C-833A-D273D9E54023
p:P2566 wd:statement/Q2146170-13572468-2468-1357-eca9-bdf024681357
p:P267 wd:statement/Q2146170-4C2446AC-3FBA-4490-A928-41DF140BE23A
p:P274 wd:statement/Q2146170-B49521E3-F603-465F-B520-C1F7CE7B82B2
p:P279 wd:statement/Q2146170-754FB32F-B61E-488B-A393-8713FC374827
p:P2868 wd:statement/Q2146170-8318DC94-77B6-48E3-8FB7-9BA1DDB3FDB9
wd:statement/Q2146170-E7A896A1-4D89-43D1-9826-EFF19490377A
p:P2877 wd:statement/Q2146170-E9DCA890-C8D8-4534-A41F-B682C13397F2
p:P2892 wd:statement/Q2146170-14E16F0B-9EB4-4400-A3C0-CE76CACECA08
p:P31 wd:statement/Q2146170-2E888C84-AFC3-4DF6-9B8C-4589788A7E69
p:P3117 wd:statement/Q2146170-7ECBB633-DCC8-4300-9388-0DF4D28F05FE
p:P3345 wd:statement/Q2146170-2AED0880-16CB-42D0-8E2B-013127037383
p:P3489 wd:statement/Q2146170-03AAF48F-D1D2-48F8-A99A-37DA7FB653DE
p:P3636 wd:statement/Q2146170-0AD41447-93C3-4135-814A-D42CDEF3FD69
p:P366 wd:statement/Q2146170-5AC0B7C0-3D0E-461E-906D-006A4BEBFB48
p:P373 wd:statement/Q2146170-3EE72022-A3E5-460E-896B-5909BE715556
p:P3780 wd:statement/Q2146170-1E14FF92-93F5-4903-8D6E-4EDB3EE1555E
wd:statement/Q2146170-5F11515C-A33B-4F56-90D5-C70A84EADEB9
p:P4250 wd:statement/Q2146170-F46E82E6-F48B-4E1E-919E-71A1DBEAB36F
p:P486 wd:statement/Q2146170-50DFD57A-6AC4-482B-8FFD-906DC993C1A7
p:P592 wd:statement/Q2146170-A07D2D53-297A-4C6D-89F1-7AEDB5A38037
p:P595 wd:statement/Q2146170-DE5FB1E3-254A-4A7E-BA3E-CF22FC81E87A
p:P6366 wd:statement/Q2146170-6A75C76C-248F-4403-9697-DC1842F9F85F
p:P646 wd:statement/Q2146170-D43B55A7-ABA0-4A19-83C1-7F69B36D12FF
p:P652 wd:statement/Q2146170-05D8C961-E329-408F-A1C7-F9C3659E2E85
p:P661 wd:statement/Q2146170-23F69B8E-655B-48FC-A965-B4D956998B6F
p:P662 wd:statement/Q2146170-A43F6BE8-B169-412D-B50F-7CCCDE0C32DF
p:P665 wd:statement/Q2146170-8DACECED-DA4E-4DD5-B86A-3053612170E9
wd:statement/Q2146170-B07D3BCC-9305-4899-A28C-54F02385196B
p:P683 wd:statement/Q2146170-A13C5C28-AB40-4E4C-9C71-1B00C8D4B6EC
p:P715 wd:statement/Q2146170-DF5D25A0-47CA-4DBB-BA88-3AC33DD70FA0
p:P7830 wd:statement/Q2146170-08A08125-18C4-4439-8E24-D1C75977BB83
p:P8026 wd:statement/Q2146170-BC00FC4B-B7A7-4BA5-914B-A8FCC2320E9F
p:P8189 wd:statement/Q2146170-853EA3F8-1AA7-4277-998F-0BD02D3D3C5D
p:P8494 wd:statement/Q2146170-323D7CE9-F5C5-4F07-9D8A-72C75A86F8A2
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000182972>
p:direct-normalized/P244 <http://id.loc.gov/authorities/names/sh2014100119>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/C101866>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL41355>
p:direct-normalized/P6366 <https://makg.org/entity/2778994288>
p:direct-normalized/P661 <http://rdf.chemspider.com/108740>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121892>
p:direct-normalized/P665 <http://www.kegg.jp/entry/C13826>
<http://www.kegg.jp/entry/D09569>
p:direct-normalized/P683 <http://purl.obolibrary.org/obo/CHEBI_68584>
wdt:P10245 "a612028"
wdt:P11089 "116007"
wdt:P11198 "4181"
wdt:P11199 "PD009342"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/Retigabine.svg>
wdt:P129 Potassium voltage-gated channel subfamily Q member 4
Potassium voltage-gated channel subfamily Q member 5
Potassium voltage-gated channel subfamily Q member 1
Potassium voltage-gated channel subfamily Q member 2
Potassium voltage-gated channel subfamily Q member 3
wdt:P14834 Schedule V (United States)
wdt:P1579 "8072099"
wdt:P2057 "HMDB0257171"
wdt:P2062 "8171"
wdt:P2067 303.138305^^xsd:decimal
wdt:P2115 "N0000182972"
wdt:P2175 epilepsy
wdt:P2275 "retigabine"@en
wdt:P231 "150812-12-7"
wdt:P232 "629-886-2"
wdt:P233 "CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N"
wdt:P234 "InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)"
wdt:P235 "PCOBBVZJEWWZFR-UHFFFAOYSA-N"
wdt:P244 "sh2014100119"
wdt:P2566 "100.158.123"
wdt:P267 "N03AX21"
wdt:P274 "C₁₆H₁₈FN₃O₂"
wdt:P279 chemical compound
wdt:P2868 membrane transport modulator
anticonvulsant agent
wdt:P2877 "20835"
wdt:P2892 "C0530684"
wdt:P31 type of chemical entity
wdt:P3117 "DTXSID40164615"
wdt:P3345 "1112990"
wdt:P3489 US pregnancy category C
wdt:P3636 "FBX"
wdt:P366 medication
wdt:P373 "Retigabine"
wdt:P3780 Trobalt
Potiga
wdt:P4250 0.9^^xsd:decimal
wdt:P486 "C101866"
wdt:P592 "CHEMBL41355"
wdt:P595 "2601"
wdt:P6366 "2778994288"
wdt:P646 "/m/05q4_qf"
wdt:P652 "12G01I6BBU"
wdt:P661 "108740"
wdt:P662 "121892"
wdt:P665 "C13826"
"D09569"
wdt:P683 "68584"
wdt:P715 "DB04953"
wdt:P7830 "Ezogabine"
wdt:P8026 LiverTox toxicity likelihood category E
wdt:P8189 "987007407424805171"
wdt:P8494 "DTXCID5087106"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata